SpringWorks Therapeutics (SWTX) Reports Q3 Loss, Lags Revenue Estimates

SpringWorks Therapeutics (SWTX) came out with a quarterly loss of $0.72 per share versus the Zacks Consensus Estimate of a loss of$ 0.76. This compares to loss of $1.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.12 per share when it actually produced a loss of $0.54, delivering a surprise of 51.79%.Over the last four quarters ...